Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Go back to Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results
(NASDAQ: AMLX) Delayed: 39.66 +1.06 (2.75%)
Previous Close $38.60    52 Week High
Open $37.49    52 Week Low
Day High $40.44    P/E N/A 
Day Low $37.37    EPS
Volume 8,540,218